Dr. Leslie A Andritsos MD Hematologist

Dr. Leslie Andritsos is a hematologist in Columbus, Ohio. She is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Hospital. She received her medical degree from University of Texas Medical Branch at Galveston and has been in practice for 15 years. Dr. Andritsos accepts several types of health insurance, listed below. She is one of 21 doctors at James Cancer Hospital and Solove Research Institute and one of 23 at Ohio State University Hospital who specialize in Hematology.

Are you Dr. Leslie Andritsos? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Hematologist: Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Hospital Affiliation

James Cancer Hospital and Solove Research Institute
Ranked #20 in Cancer

Ohio State University Hospital

Ohio State University Medical Center
Ranked #20 in Cancer

Education & Medical Training

Washington University/Barnes-Jewish Hospital
Residency, Internal Medicine, 1999 - 2001

Washington University
Fellowship, Hematology/Oncology, 2001 - 2005

University of Texas Medical Branch at Galveston
Class of 1999

Certifications & Licensure

American Board of Family Medicine
Certified in Family Medicine

American Board of Family Medicine
Certified in Sports Medicine

AL State Medical License
Active through 2012

FL State Medical License
Active through 2014

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services

Publications & Presentations

Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.
Zhong, Y.,El-Gamal, D.,Dubovsky, J. A.,Beckwith, K. A.,Harrington, B. K.,Williams, K. E.,Goettl, V. M.,Jha, S.,Mo, X.,Jones, J. A.,Flynn, J. M.,Maddocks, K. J.,Andritsos, L. A.,McCauley, D.,Shacham, S.,Kauffman, M.,Byrd, J. C.,Lapalombella, R.

The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia model.
Beckwith, K. A.,Frissora, F. W.,Stefanovski, M. R.,Towns, W. H.,Cheney, C.,Mo, X.,Deckert, J.,Croce, C. M.,Flynn, J. M.,Andritsos, L. A.,Jones, J. A.,Maddocks, K. J.,Lozanski, G.,Byrd, J. C.,Muthusamy, N.

Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center.
Stephens, D. M.,Ruppert, A. S.,Jones, J. A.,Woyach, J.,Maddocks, K.,Jaglowski, S. M.,Andritsos, L. A.,Flynn, J. M.,Grever, M. R.,Lozanski, G.,Johnson, A. J.,Muthusamy, N.,Heerema, N. A.,Byrd, J. C.

See all 33 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Anthem PPO
  • BCBS Blue Card PPO
  • BCBS Texas BlueChoice
  • CIGNA Open Access
  • Cofinity PPO
  • Coventry Carelink Health Plans PPO
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Rocky Mountain Group/Indiv - HMO/Private Pay
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.